Organogenesis Holdings (ORGO) Non-Current Deffered Revenue (2016 - 2020)

Organogenesis Holdings' Non-Current Deffered Revenue history runs 5 years deep, the most recent figure standing at $1.1 million for Q3 2020.

• On a quarterly basis, Non-Current Deffered Revenue rose 49.18% year-over-year to $1.1 million in Q3 2020; TTM through Sep 2020 was $1.1 million, a 49.18% increase from a year earlier, with the FY2019 full-year figure at $1.0 million, up 678.46% from the prior year.
• Non-Current Deffered Revenue was little changed at $1.1 million in Q3 2020 per ORGO's latest filing, from $1.1 million in the prior quarter.
• Across five years, Non-Current Deffered Revenue topped out at $10.8 million in Q4 2016 and bottomed at $52000.0 in Q1 2019.
• The 5-year median for Non-Current Deffered Revenue is $1.1 million (2020), against an average of $4.7 million.
• Across the five-year window, Non-Current Deffered Revenue tumbled 99.52% in 2019 and surged 2025.0% in 2020, its largest moves.
• Year by year, Non-Current Deffered Revenue stood at $10.8 million in 2016, then slumped by 99.32% to $74000.0 in 2017, then surged by 75.68% to $130000.0 in 2018, then jumped by 678.46% to $1.0 million in 2019, then increased by 8.5% to $1.1 million in 2020.
• Per Business Quant, the three latest ORGO Non-Current Deffered Revenue figures stand at $1.1 million (Q3 2020), $1.1 million (Q2 2020), and $1.1 million (Q1 2020).